Recent Quotes

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-10
REV		(EXPECTED)2021-08-10

Q1 2021		Est.		Actual		Surprise
EPS		-0.230		-0.250		-0.0200
REV		19.560M		16.274M		-3.286M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
BNR	Burning Rock Biotech	28.44	0.00	0%		3B

Burning Rock Biotech Frequently Asked Questions

How do I buy Burning Rock Biotech (BNR) stock?

You can purchase shares of Burning Rock Biotech (NASDAQ: BNR) through any online brokerage.

View our list of the best stock brokerages.

Who are Burning Rock Biotech's (BNR) competitors?

Other companies in Burning Rock Biotech’s space includes: Karuna Therapeutics (NASDAQ:KRTX), Sage Therapeutics (NASDAQ:SAGE), FibroGen (NASDAQ:FGEN), OPKO Health (NASDAQ:OPK) and Alkermes (NASDAQ:ALKS).

What is the target price for Burning Rock Biotech (BNR) stock?

The latest price target for Burning Rock Biotech (NASDAQ: BNR) was reported by B of A Securities on July 13, 2020. The analyst firm set a price target for 32.30 expecting BNR to rise to within 12 months (a possible 13.57% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Burning Rock Biotech (BNR)?

The stock price for Burning Rock Biotech (NASDAQ: BNR) is $28.44 last updated Wed Jun 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Burning Rock Biotech (BNR) pay a dividend?

There are no upcoming dividends for Burning Rock Biotech.

When is Burning Rock Biotech (NASDAQ:BNR) reporting earnings?

Burning Rock Biotech’s Q2 earnings are confirmed for after-market on August 10, 2021.

Is Burning Rock Biotech (BNR) going to split?

There is no upcoming split for Burning Rock Biotech.

What sector and industry does Burning Rock Biotech (BNR) operate in?

Burning Rock Biotech is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.